Profile

Allarta Life Science is a pre-clinical life science platform company developing next-generation biomaterials for immune-privileged delivery and storage, of cells, stem cells, and biologics. Allarta’s technology is based on over 35 years of foundational research in polymer science and aims to enable scale-up of global allogeneic cell-based therapies for chronic endocrine disorders such as T1D diabetes, hemophilia, and lysosomal storage and rare diseases.

Allarta Life Science logo

Website

allarta.com

Contact


Event details

Date: January 8 - 10, 2024

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences

Participants

18 in total